Canada markets close in 6 hours 20 minutes

Ultragenyx Pharmaceutical Inc. (RARE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
42.86-0.15 (-0.35%)
As of 09:37AM EDT. Market open.
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts18182020
Avg. Estimate-1.71-1.58-6.58-5.23
Low Estimate-2.13-1.84-7.51-6.83
High Estimate-1.32-1.22-4.71-2.23
Year Ago EPS-2.25-2.23-8.25-6.58
Revenue EstimateCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts16161920
Avg. Estimate122.62M132.73M511.78M627.21M
Low Estimate108.5M121.9M501.5M559M
High Estimate129.7M139.9M527.7M739M
Year Ago Sales108.31M98.05M434.25M511.78M
Sales Growth (year/est)13.20%35.40%17.90%22.60%
Earnings History2023-06-292023-09-292023-12-302024-03-30
EPS Est.-2.07-2.08-1.62-1.73
EPS Actual-2.25-2.23-1.52-2.03
Difference-0.18-0.150.1-0.3
Surprise %-8.70%-7.20%6.20%-17.30%
EPS TrendCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Current Estimate-1.71-1.58-6.58-5.23
7 Days Ago-1.64-1.59-6.37-5.01
30 Days Ago-1.63-1.58-6.44-4.96
60 Days Ago-1.63-1.58-6.45-4.9
90 Days Ago-1.6-1.5-6.28-4.35
EPS RevisionsCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days2528
Up Last 30 Days47311
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days9695
Growth EstimatesRAREIndustrySector(s)S&P 500
Current Qtr.24.00%N/AN/AN/A
Next Qtr.29.10%N/AN/AN/A
Current Year20.20%N/AN/AN/A
Next Year20.50%N/AN/AN/A
Next 5 Years (per annum)8.90%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A